Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.44B | 55.86B | 54.27B | 51.88B | 49.75B | 48.90B |
Gross Profit | 9.13B | 9.23B | 9.08B | 8.82B | 9.07B | 9.78B |
EBITDA | 1.86B | 2.44B | 2.55B | 2.29B | 2.65B | 2.65B |
Net Income | 275.59M | 384.74M | 411.64M | 243.09M | 607.55M | 700.58M |
Balance Sheet | ||||||
Total Assets | 44.12B | 39.89B | 42.61B | 40.32B | 38.58B | 37.70B |
Cash, Cash Equivalents and Short-Term Investments | 5.37B | 3.50B | 5.71B | 3.68B | 3.46B | 2.95B |
Total Debt | 9.38B | 10.90B | 11.29B | 11.49B | 10.58B | 10.86B |
Total Liabilities | 27.90B | 23.30B | 26.42B | 24.83B | 23.35B | 22.98B |
Stockholders Equity | 15.76B | 16.07B | 15.76B | 15.11B | 14.90B | 14.41B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.45B | 2.47B | -683.94M | 1.19B | 1.91B |
Operating Cash Flow | 0.00 | 48.42M | 3.60B | 1.18B | 1.89B | 3.18B |
Investing Cash Flow | 0.00 | -1.55B | -1.05B | -1.50B | -766.64M | -1.35B |
Financing Cash Flow | 0.00 | -692.74M | -516.47M | 529.86M | -653.18M | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥9.30B | 6.00 | 2.45% | 1.60% | 2.59% | ||
74 Outperform | ¥10.11B | 7.66 | 2.61% | 5.40% | 10.69% | ||
68 Neutral | ¥197.40B | 21.11 | 8.29% | 2.33% | 4.99% | 3.05% | |
64 Neutral | ¥8.92B | 23.17 | 1.63% | 2.93% | -6.54% | ||
56 Neutral | ¥3.72B | 8.31 | 3.67% | -13.39% | -170.53% | ||
46 Neutral | ¥3.57B | ― | ― | -2.27% | -526.69% | ||
44 Neutral | ¥5.16B | ― | 0.79% | -0.43% | -499.91% |